Britain fares rather badly in international comparisons of cancer patients' survival rates. Relative survival rates in England and Wales 1 are generally lower than in Europe, 2 which in turn are lower than rates in the United States. 3 The differences between England and Wales and the rest of Western Europe in survival rates for colon cancer and female breast cancer arise primarily in the first six months after diagnosis, suggesting that these differences may relate to later presentation or delays in treatment for British patients.
3 The differences between England and Wales and the rest of Western Europe in survival rates for colon cancer and female breast cancer arise primarily in the first six months after diagnosis, suggesting that these differences may relate to later presentation or delays in treatment for British patients.
Given this background, the government has pledged to "end waiting times for cancer surgery, thereby helping thousands of women waiting for breast cancer treatment." The assumption is that reduced waiting times will lead to more rapid diagnosis, earlier instigation of care, and reduced psychological morbidity. Indeed, the NHS has been asked to set a target of two weeks from referral by a general practitioner to first hospital outpatient appointment for all suspected cases of cancer.
In order to investigate the delays that British cancer patients face, we undertook a retrospective survey of patients with newly diagnosed cancer in October 1997.
Subjects, methods, and results
We invited all English acute hospital trusts (whether cancer centres or units) to submit relevant information on all new patients with a cancer diagnosis confirmed during October 1997. The data were collected during April and May 1998, allowing a tracking period of up to six months after diagnosis. We measured how long the patients were required to wait from their initial referral by their general practitioner for an outpatient appointment, for their first definitive treatment (when appropriate), and for any subsequent treatment.
Data returns were made by 218 (98%) of the 223 trusts, representing 13 454 patients. A greater proportion of patients who had been urgently referred by their general practitioner were seen within two weeks compared with those who were non-urgent referrals. However, the results clearly showed that there was substantial variation in patients' waiting times according to tumour type, whether the initial referral was coded urgent, and the region where treatment was undertaken. The table shows that waiting times for urgent appointments were significantly less than the waiting times for non-urgent appointments: this was so for all 10 types of cancer and for time from general practitioner referral to first definitive treatment as well as for time from referral to outpatient appointment.
Waiting times for cancer patients in England, from general practitioner referral to first outpatient appointment and to first definitive treatment (excluding referrals not by general practitioner) 
Discussion
The underlying causes of the variation in waiting times observed here are not explained by the audit data, and we do not suggest that there are "across the board" implications for clinical outcome in the waiting times reported. Clearly, these are clinical issues and would vary with specific types of cancer. However, the focus on reducing unnecessary delays in cancer treatment stems from the belief that the earlier disease is detected, the more quickly multidisciplinary care can be instigated and the better the outcome. Irrespective of the specific waiting times reported here, the key contribution of this study is in establishing baseline data which can be used to set targets for improvement and, crucially, to monitor such attempts.
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Relation between infants' birth weight and mothers' mortality: prospective observational study
George Davey Smith, Seeromanie Harding, Michael Rosato
Several studies have shown inverse associations between birth weight and incidence of cardiovascular disease in adulthood, 1 2 suggesting that development in early life may influence the risk of disease many years later. The existence of intergenerational influences on birth weight, illustrated by correlations between the birth weight of parents and the birth weight of their offspring, suggests that birth weight of offspring should be associated with the risk of mortality from cardiovascular disease among parents. So far only one small study has investigated this possibility. 3 In that study each kilogram decrease in birth weight of the infant was associated with a doubling in the risk of parental mortality from cardiovascular disease. We have replicated this potentially important finding in the Office for National Statistics' longitudinal study, a follow up of 1% of the population of England and Wales from the 1971 census. 
Methods and results
In the longitudinal study, information from birth registrations of infants during 1976-97 is linked to data from the census and death registration (1976-97) for study members. Birth weight was collected from 1976 onwards, but during the 1970s the data were not complete. The first recorded birth weight of infants to 44 813 women aged 15-45 years at birth registration was used as the exposure measure. Mean birth weight was 3210 g (SD 566 g). The average birth weight changed little over the study period (4.6 g increase a year, 95% confidence intervals 3.6 g to 5.6 g). The difference between average male birth weight and average female birth weight (99 g) was subtracted from each male birth weight. Socioeconomic position (housing tenure and car access) of mothers was taken from the 1971 census.
Mortality was analysed by using Cox's proportional hazards model in relation to birth weight, with adjustment for socioeconomic position and whether the birth occurred inside or outside marriage (with additional adjustment for sole registration or joint registration if outside marriage).
The table shows a substantial association between infants' birth weight and mothers' mortality from all causes and from cardiovascular disease. The relative risk of maternal cardiovascular mortality associated with a 1 kg lower birth weight in offspring was closely similar to that seen in the previous study of this issue (2.00 (1.18 to 3.33) 3 ); the corresponding associated risks for the other two major causes of death (153 deaths from cancer (1.33; 1.03 to 1.72) and 38 accidental or violent deaths (1.06; 0.61 to 1.85)) were considerably smaller than those for cardiovascular mortality.
